BioCentury
ARTICLE | Clinical News

Denosumab regulatory update

March 26, 2012 7:00 AM UTC

Daiichi Sankyo said it submitted a regulatory application in Japan for denosumab to treat osteoporosis. The human mAb targeting receptor activator of NF-kappa B ligand ( RANKL) is approved in Japan a...